BMC GASTROENTEROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2022-12-28 john2525 来自四川省

千万不要投，超级超级慢！3个月了还在initial technical check.

78 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2021-08-04 prima

这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？

78 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2022-09-01 ms5000000377833445

Editor invited 快一个月了，编辑也要邀请吗

81 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2021-06-24 14898ab0m38(暂无昵称)

偏重的研究方向：肿瘤
经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！

117 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2021-04-26 vdujun

偏重的研究方向：胃癌
经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新

267 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2023-08-26 ms5000000089678974 来自江苏省

BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？

41 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2022-05-30 ms4000000222994216

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：普外
经验分享：肿瘤，3.15提交，期间修改一次，5.30接收

83 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2021-11-13 145c5dd8m51暂无昵称

2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。

209 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2022-09-20 小小医者

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌
经验分享：BMC类相对发表容易，不过审稿周期偏长了

58 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2107923, encodeId=55ea210e9238a, content=千万不要投，超级超级慢！3个月了还在initial technical check., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/11/27/02ec99199da3be64e02e6f44937ab158.jpg, createdBy=1c582101660, createdName=john2525, createdTime=Wed Dec 28 20:43:39 CST 2022, time=2022-12-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1005136, encodeId=85e81005136b1, content=这个杂志现在research article 投稿要求投到一个新的系统，但是新系统quality check in progress 已经20几天了，这个新系统请问有人投过吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dd701628022, createdName=prima, createdTime=Wed Aug 04 15:43:58 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242389, encodeId=75c3124238987, content=Editor invited 快一个月了，编辑也要邀请吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60168219456, createdName=ms5000000377833445, createdTime=Thu Sep 01 08:34:17 CST 2022, time=2022-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976497, encodeId=85909e649797, content=偏重的研究方向：肿瘤 经验分享：4月18提交，6月初返修，6.22接受，好快，编辑友好！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6045315599, createdName=14898ab0m38(暂无昵称), createdTime=Thu Jun 24 11:58:51 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960634, encodeId=adee9606342c, content=偏重的研究方向：胃癌 经验分享：2021年3月17号投稿， 19号编辑确认， 23号外审。目前为止邀请了23个审稿人， 4月23号5个审稿人accepted， 4月24号1个审稿人意见返回， ......持续更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/09/04/700865284ff0a20865522250bbdae373.jpg, createdBy=1d172433504, createdName=vdujun, createdTime=Mon Apr 26 15:05:57 CST 2021, time=2021-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154680, encodeId=f0192154680bf, content=BMC Gastroenterology Reviewer reports received / Ready for editor’s decision已经20天了拒稿的可能性大吗？要不要再催一下呢？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77288434892, createdName=ms5000000089678974, createdTime=Sat Aug 26 12:16:15 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223481, encodeId=59ab122348153, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：普外 经验分享：肿瘤，3.15提交，期间修改一次，5.30接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecfc5706039, createdName=ms4000000222994216, createdTime=Mon May 30 23:51:12 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069831, encodeId=43901069831a7, content=2021.03.29投稿，2021.11.08接受，中间经历一次修改。一篇病例报告，胆道方向。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7105087078, createdName=145c5dd8m51暂无昵称, createdTime=Sat Nov 13 10:11:47 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2089163, encodeId=058f20891638f, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：胃肠道;神经内分泌肿瘤;结直肠癌 经验分享：BMC类相对发表容易，不过审稿周期偏长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Tue Sep 20 02:16:23 CST 2022, time=2022-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219477, encodeId=fff712194e70c, content=投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ca72156376, createdName=1202183cm33(暂无昵称), createdTime=Fri May 13 22:24:38 CST 2022, time=2022-05-13, status=1, ipAttribution=)]

2022-05-13 1202183cm33(暂无昵称)

投稿到现在6个月了，3.22收到一个审稿人意见，到现在一直没下文，龟速审稿？

90 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务